The New England journal of medicine
-
Editorial Comment
Acute Myeloid Leukemia - Many Diseases, Many Treatments.
-
Editorial Comment
CDK4 and CDK6 Inhibition in Breast Cancer - A New Standard.
-
Editorial Comment
First-in-Human Clinical Trials - What We Can Learn from Tragic Failures.